Drug intelligence / Profile preview

Sanhuang Yishen Capsule + semaglutide

Development stage: Preclinical
Lead developer: Novo Nordisk
Modality: Peptides
Administration: Oral, Subcutaneous

Overview

Sanhuang Yishen Capsule + semaglutide is a combination therapy consisting of the Traditional Chinese Medicine (TCM) Sanhuang Yishen Capsule and the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide. Sanhuang Yishen Capsule is a Chinese patent medicine typically used to treat diabetic kidney disease (DKD) by tonifying the kidney, resolving blood stasis, and clearing heat. Semaglutide is a long-acting GLP-1 receptor agonist that enhances glucose-dependent insulin secretion and has demonstrated significant cardiovascular and renal protective benefits. This combination is primarily investigated in clinical research in China for its potential synergistic effects in managing type 2 diabetes mellitus complicated by diabetic nephropathy, aiming to improve glycemic control while reducing proteinuria and slowing the progression of renal impairment.

Other names: 三黄益肾胶囊 + 司美格鲁肽Sanhuang Yishen Capsule and semaglutide

Targets

GLP1R (GLP-1R)

Beyond the preview

Go deeper on Sanhuang Yishen Capsule + semaglutide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sanhuang Yishen Capsule + semaglutide.

Explore the full profile